Research Paper Volume 13, Issue 1 pp 794—812
Systematic construction and validation of an epithelial–mesenchymal transition risk model to predict prognosis of lung adenocarcinoma
Figure 8. Differences in the immune landscape between low- and high-risk patients with LUAD. (A) Relative proportions of immune cell infiltration in the high- and low-risk patients. (B) Vioplot visualization of significantly different proportions of immune cells between low- and high-risk patients.